Feasibility Study of Neo-adjuvant Treatment With Carboplatin, Paclitaxel and Pembrolizumab in Primary Stage IV Serous Ovarian Cancer
Phase of Trial: Phase I/II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Pharmacodynamics
- 15 Nov 2017 Status changed from not yet recruiting to recruiting.
- 13 Sep 2017 Planned initiation date changed from 1 Jun 2017 to 1 Oct 2017.
- 26 Apr 2017 New trial record